Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Junpeng Meng"'
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundThe relationship between family income to poverty ratio (PIR) and severe headache/migraine remains unclear.MethodsData for this cross-sectional study were obtained from NHANES 1999–2004. PIR was the exposure variable, and severe headache/
Externí odkaz:
https://doaj.org/article/9cf10e8d336640a28a918e5118bf4cbd
Autor:
Xiaoqi Liu, Hai Xiao, Mingxia Luo, Junpeng Meng, Lin Zhong, Tao Wu, Yongxia Zhao, Faming Wu, Jian Xie
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction:P. candolleana Wight et Arn. Is a traditional Chinese herbal medicine used by the Gelao nationality in southwest China, has been historically applied to treat various gastrointestinal disorders. Despite its traditional usage, scientific
Externí odkaz:
https://doaj.org/article/c30c44e5db8e4e6c8442c6ea6c333379
Publikováno v:
Cellular Oncology. 45:1421-1434
Integrin alpha 2 (ITGA2, also known as CD49b or VLA-2) is the alpha subunit of a transmembrane receptor for collagens and related proteins. Previously, we found that ITGA2 may regulate immune cell infiltration in pancreatic cancer by inducing PD-L1 e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada00866be40ac2f537a30fd6b178546
https://doi.org/10.1007/s13402-022-00731-3
https://doi.org/10.1007/s13402-022-00731-3
Publikováno v:
Cell reports. 40(7)
Sorafenib is currently the first-line treatment for advanced hepatocellular carcinoma (HCC). However, sorafenib resistance remains a significant challenge. Aberrant AKT signaling activation is a crucial mechanism driving sorafenib resistance in HCC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb84cbda1a5907536c4f3c2f192c26fe
https://pubmed.ncbi.nlm.nih.gov/35977495
https://pubmed.ncbi.nlm.nih.gov/35977495
Publikováno v:
Journal of Hepatocellular Carcinoma; Sep2024, Vol. 11, p1763-1775, 13p
Autor:
Meng, Junpeng1,2 (AUTHOR), Cai, Hongkun1 (AUTHOR), Sun, Yan1 (AUTHOR), Wen, Shuang3 (AUTHOR) 137428315@qq.com, Wu, Heshui1 (AUTHOR) heshuiwu@hust.edu.cn, Ren, Dianyun1 (AUTHOR) rendianyun@hust.edu.cn
Publikováno v:
Cellular Oncology (2211-3428). Dec2022, Vol. 45 Issue 6, p1421-1434. 14p.
Publikováno v:
Drug Week; 4/26/2024, p2820-2820, 1p